99805-19-3

Basic information

• Product Name: 2-Propanol, 1-azido-3-(phenylmethoxy)-
• CAS NO: 99805-19-3
• Molecular Formula: C10H13N3O2
• Molecular Weight: 207.232
• Mol File: 99805-19-3.mol
• Article Data: 16

Chemical Properties

• CAS DataBase Reference: 2-Propanol, 1-azido-3-(phenylmethoxy)-(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Propanol, 1-azido-3-(phenylmethoxy)-(99805-19-3)
• EPA Substance Registry System: 2-Propanol, 1-azido-3-(phenylmethoxy)-(99805-19-3)

Safety Data

• Hazardous Substances Data: 99805-19-3(Hazardous Substances Data)

Upstream product

• 100-51-6 benzyl alcohol 
• 100-39-0 benzyl bromide 
• 13071-59-5 3-benzyloxypropan-1,2-diol 
• 2930-05-4 Benzyloxymethyl-oxiran 
• 4704-76-1 4-(benzyloxymethyl)-1,3-dioxo-2-thiolane 2-oxide 

Downstream Products

• 1030386-25-4 1-N-(trifluoroacetyl)-3-(phenylmethoxy)propan-2-ol 
• 1376644-30-2 C₁₀H₁₃NO 
• 1335200-07-1 4-((benzyloxy)methyl)-2-(3,5-dinitrophenyl)-4,5-dihydrooxazole 
• 1335199-95-5 (2-((benzyloxy)methyl)aziridine-1-yl)(3,5-dinitrophenyl)methanone 
• 1350896-42-2 C₂₀H₂₃N₃O₃ 
• 4698-86-6 3-(3-chlorophenoxy)-2-hydroxypropylamine 
• 90503-15-4 (RS)-(3-benzyloxy-2-hydroxypropyl)amine 
• 141870-42-0 trans-5-benzyloxymethyl-3-formyl-2-methyl-1,3-oxazolidine 
• 141870-42-0 cis-5-benzyloxymethyl-3-formyl-2-methyl-1,3-oxazolidine 
• 137431-18-6 (R,S)-1-<(1-azido-3-benzyloxy-2-propoxy)methyl>thymine 
• 162314-53-6 (R,S)-(1-azido-3-benzyloxy-2-propoxy)methyl phenyl sulfide 
• 137431-20-0 (R,S)-(1-azido-3-benzyloxy-2-propoxy)methyl chloride 

Relevant articles and documents

Silica-tethered cuprous acetophenone thiosemicarbazone (STCATSC) as a novel hybrid nano-catalyst for highly efficient synthesis of new 1,2,3-triazolyl-based metronidazole hybrid analogues having potent antigiardial activity

The preparation, characterization and application of silica-tethered cuprous acetophenone thiosemicarbazone (STCATSC) as a novel hybrid nano catalyst for synthesis of new 1,2,3-triazolyl-based metronidazole hybrid analogues is described. STCATSC is fully

HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USES THEREOF

The present invention relates to compounds of Formula (I) and pharmaceutically acceptable compositions thereof, useful as IRAK inhibitors.

GLS1 INHIBITORS FOR TREATING DISEASE

Disclosed herein are compounds and compositions useful in the treatment of GLS1 mediated diseases, such as cancer, having the structure of Formula I. Methods of inhibition GLS1 activity in a human or animal subject are also provided.